480 related articles for article (PubMed ID: 11432973)
1. Morphine-induced in vivo release of spinal cholecystokinin is mediated by delta-opioid receptors--effect of peripheral axotomy.
Gustafsson H; Afrah AW; Stiller CO
J Neurochem; 2001 Jul; 78(1):55-63. PubMed ID: 11432973
[TBL] [Abstract][Full Text] [Related]
2. Effects of opioid receptor antagonists on the effects of i.v. morphine on carrageenin evoked c-Fos expression in the superficial dorsal horn of the rat spinal cord.
Catheline G; Le Guen S; Besson JM
Brain Res; 1999 Apr; 824(1):105-11. PubMed ID: 10095048
[TBL] [Abstract][Full Text] [Related]
3. Mu and delta opioid receptors mediate opposite modulations by morphine of the spinal release of cholecystokinin-like material.
Benoliel JJ; Collin E; Mauborgne A; Bourgoin S; Legrand JC; Hamon M; Cesselin F
Brain Res; 1994 Aug; 653(1-2):81-91. PubMed ID: 7982079
[TBL] [Abstract][Full Text] [Related]
4. Delta(2)-opioid receptor mediation of morphine-induced CCK release in the frontal cortex of the freely moving rat.
Becker C; Hamon M; Cesselin F; Benoliel JJ
Synapse; 1999 Oct; 34(1):47-54. PubMed ID: 10459171
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
Hammond DL; Wang H; Nakashima N; Basbaum AI
J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
[TBL] [Abstract][Full Text] [Related]
6. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
7. Peripheral axotomy influences the in vivo release of cholecystokinin in the spinal cord dorsal horn-possible involvement of cholecystokinin-B receptors.
Gustafsson H; de Araújo Lucas G; Schött E; Stiller CO; Alster P; Wiesenfeld-Hallin Z; Brodin E
Brain Res; 1998 Apr; 790(1-2):141-50. PubMed ID: 9593865
[TBL] [Abstract][Full Text] [Related]
8. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception.
Cahill CM; Morinville A; Lee MC; Vincent JP; Collier B; Beaudet A
J Neurosci; 2001 Oct; 21(19):7598-607. PubMed ID: 11567050
[TBL] [Abstract][Full Text] [Related]
9. Axotomy reduces the effect of analgesic opioids yet increases the effect of nociceptin on dorsal root ganglion neurons.
Abdulla FA; Smith PA
J Neurosci; 1998 Dec; 18(23):9685-94. PubMed ID: 9822729
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of morphine-induced in vivo release of cholecystokinin in rat dorsal horn: effects of ion channel blockers.
Gustafsson H; Afrah A; Brodin E; Stiller CO
J Neurochem; 1999 Sep; 73(3):1145-54. PubMed ID: 10461906
[TBL] [Abstract][Full Text] [Related]
11. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
12. Morphine tolerance in spinal cord is due to interaction between mu- and delta-receptors.
Riba P; Ben Y; Smith AP; Furst S; Lee NM
J Pharmacol Exp Ther; 2002 Jan; 300(1):265-72. PubMed ID: 11752125
[TBL] [Abstract][Full Text] [Related]
13. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
[TBL] [Abstract][Full Text] [Related]
14. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
[TBL] [Abstract][Full Text] [Related]
15. Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors.
Yoshida Y; Koide S; Hirose N; Takada K; Tomiyama K; Koshikawa N; Cools AR
Neuroscience; 1999; 92(4):1357-65. PubMed ID: 10426490
[TBL] [Abstract][Full Text] [Related]
16. Effect of morphine on cholecystokinin and mu-opioid receptor-like immunoreactivities in rat spinal dorsal horn neurons after peripheral axotomy and inflammation.
Zhang X; de Araujo Lucas G; Elde R; Wiesenfeld-Hallin Z; Hökfelt T
Neuroscience; 2000; 95(1):197-207. PubMed ID: 10619476
[TBL] [Abstract][Full Text] [Related]
17. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
18. Differential release of cholecystokinin by morphine in rat spinal cord.
de Araujo Lucas G; Alster P; Brodin E; Wiesenfeld-Hallin Z
Neurosci Lett; 1998 Mar; 245(1):13-6. PubMed ID: 9596344
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
Mitrovic I; Napier TC
J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
[TBL] [Abstract][Full Text] [Related]
20. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
